Resource impact
NICE has produced a resource impact assessment tool for tirzepatide.
NICE estimates that the total eligible population is 3.4 million people, and expects that an interim NHS England commissioning policy will identify at least 220,000 people in England eligible for tirzepatide to be funded within the first 3 years of implementation.